Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Trade Show

Longhorn Vaccines and Diagnostics to Present at The Allen D. Leman Swine Conference

Longhorn Vaccines and Diagnostics LLC, a One Health and One World company developing vaccines and diagnostic tools for global public health and zoonosis concerns, today announced that Jerry Torrison, DVM, PhD, Senior Vice President of Animal Health, will present at the Allen D. Leman Swine Conference, being held in the St. Paul River Center, Minnesota, on Sept. 17 ? 20, 2022.

Dr. Torrison will be giving the Morrison Lectureship, named in honor of Dr. Bob Morrison, his PhD advisor, for his work in the areas of swine disease epidemiology and factors that drive economics and productivity in the swine industry.

Presentation Title: FADs,..Are We Ready (Together)?
Presenter: Jerry Torrison, DVM, PhD, Senior Vice President of Animal Health at Longhorn Vaccines and Diagnostics
Abstract Title: Foreign Animal Disease (FAD) Response
Session Date: Sept. 20, 2022
Session Time: 9:00 ? 10:00am CST
Session Location: The St. Paul River Centre, Minnesota

About Longhorn Vaccines and Diagnostics LLC

Longhorn Vaccines and Diagnostics LLC is a One Health company based in Maryland that is developing vaccines and diagnostic tools for worldwide public health concerns and to prevent future pandemics. Since its inception in 2006, Longhorn has focused on developing vaccines and diagnostic tools that can impact a pandemic on a global scale and at all socio-economic levels. Since pandemics flow between humans and animals, Longhorn caters to both in order to surveil, diagnose, prevent and treat the next infectious disease.

Longhorn's core product, PrimeStore® Molecular Transport Medium (MTM), is a patented, FDA cleared, state-of-the-art ambient temperature molecular diagnostic collection and transport device that can help governments, global health organizations, and drug manufacturers improve the diagnosis and treatment of highly infectious diseases such as Influenza, SARS-CoV-2, and Mycobacterium tuberculosis (TB). Unlike standard devices for collecting and transporting virus samples, PrimeStore® MTM is the first molecular transport device that can safely deactivate pathogens and stabilize RNA and DNA, allowing enhanced point of care and ambient temperature transport for laboratory based molecular testing and characterization.

These press releases may also interest you

at 06:05
SimBioSys, the precision oncology company behind the 4D Tumor Modelingtm technology, is presenting their latest breast cancer research and introducing new technology applications at the 2022 San Antonio Breast Cancer Symposium (SABCS). SimBioSys will...

at 06:05
Alzheon, Inc., a clinical-stage biopharmaceutical company developing a broad portfolio of product candidates and diagnostic assays for patients suffering from Alzheimer's disease (AD) and other neurodegenerative disorders, today announced that it has...

at 06:05
NanoString Technologies, Inc. , a leading provider of life science tools for discovery and translational research, today announced the first commercial shipment of the CosMxtm Spatial Molecular Imager (SMI) and the AtoMxtm Spatial Informatics...

at 06:05
Molecular Targeting Technologies, Inc. (MTTI) announces the issuance of Chinese Patent CN109153641B covering MTTI's lead radiotherapeutic product, EBTATEtm and others in its EvaTheratm platform. Approval of "Chemical conjugates of Evans blue...

at 06:00
As Canada's health system crisis continues, the Canadian Medical Association (CMA) and a panel of experts will examine how health care is delivered across the country in the second installment of Health Summit Series: Bold Choices in Health Care, a...

at 06:00
Today, The Leapfrog Group announced the 2022 recipients of its annual Top Hospital Award and Top Ambulatory Surgery Center (ASC) Award, a national recognition widely acknowledged as one of the most competitive awards United States hospitals and ASCs...

News published on 19 september 2022 at 08:10 and distributed by: